These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18955891)

  • 1. Health benefits, risks, and cost-effectiveness of influenza vaccination in children.
    Fleming DM; Elliot AJ
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S154-8. PubMed ID: 18955891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants.
    Black SB; Shinefield HR; France EK; Fireman BH; Platt ST; Shay D;
    Am J Perinatol; 2004 Aug; 21(6):333-9. PubMed ID: 15311370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory illness associated with influenza and respiratory syncytial virus infection.
    Fleming DM; Pannell RS; Elliot AJ; Cross KW
    Arch Dis Child; 2005 Jul; 90(7):741-6. PubMed ID: 15855178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.
    Nichol KL; D'Heilly SJ; Greenberg ME; Ehlinger E
    Clin Infect Dis; 2009 Feb; 48(3):292-8. PubMed ID: 19115970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality.
    Manzoli L; Schioppa F; Boccia A; Villari P
    Pediatr Infect Dis J; 2007 Feb; 26(2):97-106. PubMed ID: 17259870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
    Nichol KL; Mendelman P
    Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic.
    Carrat F; Flahault A; Boussard E; Farran N; Dangoumau L; Valleron AJ
    J Epidemiol Community Health; 1998 Apr; 52 Suppl 1():32S-38S. PubMed ID: 9764269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
    Fiore AE; Epperson S; Perrotta D; Bernstein H; Neuzil K
    Pediatrics; 2012 Mar; 129 Suppl 2():S54-62. PubMed ID: 22383482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.
    Salleras L; Domínguez A; Pumarola T; Prat A; Marcos MA; Garrido P; Artigas R; Bau A; Brotons J; Bruna X; Català P; Carreras E; Cuadra D; Gatell A; Millet S; Oller J; Raga E
    Vaccine; 2006 Nov; 24(44-46):6638-42. PubMed ID: 16842892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
    Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
    Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long time trends in influenza-like illness and associated determinants in The Netherlands.
    Dijkstra F; Donker GA; Wilbrink B; Van Gageldonk-Lafeber AB; Van Der Sande MA
    Epidemiol Infect; 2009 Apr; 137(4):473-9. PubMed ID: 18789176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the impact of childhood influenza vaccination programmes in England and Wales.
    Vynnycky E; Pitman R; Siddiqui R; Gay N; Edmunds WJ
    Vaccine; 2008 Sep; 26(41):5321-30. PubMed ID: 18647634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification.
    Ochiai H; Fujieda M; Ohfuji S; Fukushima W; Kondo K; Maeda A; Nakano T; Kamiya H; Hirota Y;
    Vaccine; 2009 Nov; 27(50):7031-5. PubMed ID: 19786133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.